Sarah A. Morris, PharmD

Levine Cancer Institute, Atrium Health

Sarah Morris, PharmD, is a Clinical Pharmacogenomics Specialist at Levine Cancer Institute, Atrium Health in Charlotte, North Carolina. She earned her PharmD from the University of California, San Diego and completed her PGY1 residency training at Stanford Health Care and PGY2 in Clinical Pharmacogenomics at St. Jude Children’s Research Hospital. She is currently involved in pharmacogenomics related research within the Levine Cancer Institute as well as the clinical implementation and integration of pharmacogenomics throughout the Atrium Health enterprise.

Poster(s):

• P-122 - IMPACT OF CYP3A4, CYP3A5, AND ABCB1 ON ORAL TACROLIMUS (TAC) CONCENTRATIONS WHEN TRANSITIONING FROM CONTINUOUS INFUSION INTRAVENOUS (IV) TO ORAL FORMULATION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (HCT) RECIPIENTS.